C‐reactive protein and systemic lupus erythematosus
- 26 November 2008
- journal article
- research article
- Published by Wiley in Arthritis Care & Research
- Vol. 59 (12), 1814-1820
- https://doi.org/10.1002/art.24316
Abstract
No abstract availableThis publication has 91 references indexed in Scilit:
- Long-Term Interleukin-6 Levels and Subsequent Risk of Coronary Heart Disease: Two New Prospective Studies and a Systematic ReviewPLoS Medicine, 2008
- C-Reactive Protein, Inflammatory Conditions, and Cardiovascular Disease RiskThe American Journal of Medicine, 2007
- Antibodies to C reactive proteinAnnals Of The Rheumatic Diseases, 2006
- Prevention and reversal of nephritis in MRL/lpr mice with a single injection of C‐reactive proteinArthritis & Rheumatism, 2005
- Delayed lupus onset in (NZB × NZW)F1 mice expressing a human C‐reactive protein transgeneArthritis & Rheumatism, 2003
- Identification of Acute-Phase Proteins (APP) in Circulating Immune Complexes (CIC) in Esophageal Cancer Patients' SeraCancer Investigation, 1996
- TNFα, IL-1β and IL-6 plasma levels in neutropenic patients after onset of fever and correlation with the C-reactive protein (CRP) kinetic valuesInfection, 1994
- Interleukin 4 inhibits the production of some acute‐phase proteins by human hepatocytes in primary cultureFEBS Letters, 1993
- Interleukin‐6 is the major regulator of acute phase protein synthesis in adult human hepatocytesFEBS Letters, 1989
- Significance of serum c‐reactive protein elevation in patients with systemic lupus erythematosusArthritis & Rheumatism, 1979